Description
This project is to amalgamate, analyse and report all relevant field and laboratory trials for Biotraps around the globe and also begin development of our pesticide-free Biotraps for distribution nationally and abroad.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02019-06-01$30,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2019-06-01(start date) | $30,000 | — | This project is to amalgamate, analyse and report all relevant field and laboratory trials for Biotraps around… |
Related records · 8
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 821160447)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2022-2023-Q2-993492 | National Research Council Canada | Conseil national de recherches Canada · CanExport SMEs | $22,000 | FY2023 |
| 062-2022-2023-Q4-00284 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Jobs and Growth Fund (JGF) | $3,500,000 | FY2022 |
| 172-2018-2019-Q2-911882 | National Research Council Canada | Conseil national de recherches Canada · CanExport | $28,500 | FY2019 |
Other recipients funded under "Industrial Research Assistance Program – Youth Employment Program" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1043891 | Ripple Therapeutics Corporation | FY2027 | $25,000 | FY2027 |
| 172-2026-2027-Q1-1044015 | BackSCNR Inc. | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1043828 | Marwood Ltd. | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1043785 | PURITY-IQ INCORPORATED | FY2027 | $30,000 | FY2027 |
| 172-2026-2027-Q1-1044062 | Smart City Water Inc. | FY2027 | $30,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q2-932290 · retrieved 2026-11-16.